Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Phytomedicine ; 8(3): 184-94, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11417911

RESUMO

The studies were carried out on Balb/c mice (5-6 weeks of age) treated with a peat-based preparation (PBP), administered i.p. once or four times at 24 h intervals at doses of 0.01; 0.1 or 1 mg/kg. Additionally, hydrocortisone was injected i.p. to selected mice at a single dose of 125 mg/kg. The results show that PBP temporarily enhances the proliferative capability of murine thymocytes stimulated in vitro with concanavalin A (Con A) and phytohemagglutinin (PHA). The effect of PBP depends on the number of subsequent doses, but does not depend on the dose applied. A single PBP administration does not affect the proliferative response of thymocytes to Con A and PHA. A single injection of PBP (doses from 0.01 to 1 mg/kg) does not change the number of thymic cells and weight ratio of this organ. Increased doses of subsequent PBP injections (0.01 and 0.1 mg/kg) do not affect the number of thymocytes, but temporarily increase the weight ratio of the thymus two days after the last injection. Administration of PBP prior to hydrocortisone prevents the suppressive effect of the drug on proliferative response of thymocytes stimulated in vitro with Con A and PHA, at the same time increasing the proliferative response of thymic cells to the two mitogens in relation to the control group (hydrocortisone-free). The effect of a single dose of PBP depends on the dose applied--the weakest preventive effect was observed at a dose of 0.01 mg/kg. An increase in the number of subsequent PBP doses, irrespective of a dose applied, prolongs the protective action of the drug on proliferative activity of thymocytes stimulated in vitro with these mitogenes. Moreover, the results obtained in the studies show that PBP partially prevents the suppressive effect of hydrocortisone, as the number of thymic cells and weight ratio of this organ drastically decreased. PBP accelerates regeneration of the thymus, but this depends on a dose applied and the number of subsequent doses. The result was the strongest and the fastest when PBP was injected four times at a dose of 1 mg/kg. It seems quite likely that the thymic regeneration due to PBP is connected with the effect of this drug on maturation and differentiation of thymic cells.


Assuntos
Adjuvantes Imunológicos/farmacologia , Aminoácidos/farmacologia , Carboidratos/farmacologia , Substâncias Húmicas/farmacologia , Solo , Timo/efeitos dos fármacos , Ácidos Urônicos/farmacologia , Animais , Formação de Anticorpos/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Concanavalina A/farmacologia , Relação Dose-Resposta Imunológica , Combinação de Medicamentos , Glicosilação , Hidrocortisona/farmacologia , Terapia de Imunossupressão , Interleucina-2/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Fito-Hemaglutininas/farmacologia , Formação de Roseta , Análise Espectral , Baço/efeitos dos fármacos , Baço/imunologia , Timo/citologia
2.
Wiad Lek ; 46(23-24): 912-4, 1993 Dec.
Artigo em Polonês | MEDLINE | ID: mdl-7900387

RESUMO

During 10 years patients with malignant melanoma were followed up after radical removal of primary tumour and metastatic regional lymph nodes, the half of whom was given immunomodulation with the preparation Poly-A Poly-U in a controlled clinical trial. It was found that the performed immunomodulation exerted slight effect on the course of malignant melanoma causing later development of recurrence, less dynamic course of the disease, longer asymptomatic periods in relation to the control group. No effect of the drug administration was observed on longterm survival.


Assuntos
Imunoterapia , Melanoma/terapia , Poli A-U/uso terapêutico , Neoplasias Cutâneas/terapia , Quimioterapia Adjuvante , Humanos , Excisão de Linfonodo , Metástase Linfática , Melanoma/mortalidade , Melanoma/secundário , Recidiva Local de Neoplasia/prevenção & controle , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/patologia , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...